In humans, null mutations in POMC lead to hyperphagia, early-onset obesity, isolated adrenocorticotropin (ACTH) deficiency, and hypopigmentation of skin and hair (Coll et al. 2007). The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.